chr9-4117942-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001042413.2(GLIS3):c.1536C>A(p.Asp512Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,614,060 control chromosomes in the GnomAD database, including 303 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001042413.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLIS3 | NM_001042413.2 | c.1536C>A | p.Asp512Glu | missense_variant | 4/11 | ENST00000381971.8 | NP_001035878.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLIS3 | ENST00000381971.8 | c.1536C>A | p.Asp512Glu | missense_variant | 4/11 | 5 | NM_001042413.2 | ENSP00000371398 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0140 AC: 2136AN: 152162Hom.: 36 Cov.: 31
GnomAD3 exomes AF: 0.0167 AC: 4187AN: 251232Hom.: 59 AF XY: 0.0180 AC XY: 2450AN XY: 135780
GnomAD4 exome AF: 0.0171 AC: 24949AN: 1461780Hom.: 267 Cov.: 39 AF XY: 0.0177 AC XY: 12838AN XY: 727188
GnomAD4 genome AF: 0.0140 AC: 2133AN: 152280Hom.: 36 Cov.: 31 AF XY: 0.0144 AC XY: 1076AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 04, 2013 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 18, 2016 | - - |
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | GLIS3: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 19, 2021 | This variant is associated with the following publications: (PMID: 28444304, 31415576) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Diabetes mellitus Benign:1
Benign, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Mutations in GLIS3 gene predisposes to neonatal diabetes mellitus with an extra pancreatic manifestation of hypothyroidism. rs148199056 (p.D512E) also predisposes to early onset diabetes in adults. However, Its significance in predisposition to MODY remains unclear. - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Aug 10, 2018 | ACMG criteria: (REVEL = 0.123, PP3/3 predictors, BP4,7 predictors = conflicting evidence, not using), BA1 (1.7% overall MAF in gnomAD; 3.97% in EF, 2% in SA and ENF pop), BS2 (58 homozygotes in gnomAD)=benign - |
Neonatal diabetes mellitus with congenital hypothyroidism Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at